Björn Walse

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Klebsiella Pneumoniae

Silver Nanoparticles

Top Venues

Nature communications

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Ganna Petruk, Manoj Puthia, Firdaus Samsudin, Jitka Petrlova, Franziska Olm, Margareta Mittendorfer, Snejana Hyllén, Dag Edström, Ann-Charlotte Strömdahl, Carl Diehl, Simon Ekström, Björn Walse, Sven Kjellström, Peter John Bond, Sandra Lindstedt, Artur Schmidtchen
Author Correction: Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs. Nature communications 14 (1) (2023)
Ganna Petruk, Manoj Puthia, Firdaus Samsudin, Jitka Petrlova, Franziska Olm, Margareta Mittendorfer, Snejana Hyllén, Dag Edström, Ann-Charlotte Strömdahl, Carl Diehl, Simon Ekström, Björn Walse, Sven Kjellström, Peter John Bond, Sandra Lindstedt, Artur Schmidtchen
Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs. Nature communications 14 (1) (2023)
Mark F Maurer, Katherine E Lewis, Joseph L Kuijper, Dan Ardourel, Chelsea J Gudgeon, Siddarth Chandrasekaran, Sherri L Mudri, Kayla N Kleist, Chris Navas, Martin F Wolfson, Mark W Rixon, Ryan Swanson, Stacey R Dillon, Steven D Levin, Yengo Raymond Kimbung, Masato Akutsu, Derek T Logan, Björn Walse, Kristine M Swiderek, Stanford L Peng
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity. Nature communications 13 (1) (2022)
Suado M Abdillahi, Tobias Maaß, Gopinath Kasetty, Adam A Strömstedt, Maria Baumgarten, Ramesh Tati, Sara L Nordin, Björn Walse, Raimund Wagener, Artur Schmidtchen, Matthias Mörgelin
Collagen VI Contains Multiple Host Defense Peptides with Potent In Vivo Activity. Journal of immunology (Baltimore, Md. : 1950) 201 (3) (2018)